135 related articles for article (PubMed ID: 32784359)
1. Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections.
Helal M; Allen KJH; Burgess H; Jiao R; Malo ME; Hutcheson M; Dadachova E; Snead E
Molecules; 2020 Aug; 25(16):. PubMed ID: 32784359
[No Abstract] [Full Text] [Related]
2. Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody.
Helal M; Allen KJH; van Dijk B; Nosanchuk JD; Snead E; Dadachova E
Front Microbiol; 2020; 11():147. PubMed ID: 32117166
[TBL] [Abstract][Full Text] [Related]
3. Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-biotin.
Yao Z; Zhang M; Garmestani K; Axworthy DB; Mallett RW; Fritzberg AR; Theodore LJ; Plascjak PS; Eckelman WC; Waldmann TA; Pastan I; Paik CH; Brechbiel MW; Carrasquillo JA
Clin Cancer Res; 2004 May; 10(9):3137-46. PubMed ID: 15131055
[TBL] [Abstract][Full Text] [Related]
4. Conditioning with α-emitter based radioimmunotherapy in canine allogeneic hematopoietic cell transplantation.
Kornblit B; Chen Y; Sandmaier BM
Chimerism; 2012; 3(2):40-2. PubMed ID: 22772070
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of radioimmunotherapy of experimental pneumococcal infection.
Dadachova E; Burns T; Bryan RA; Apostolidis C; Brechbiel MW; Nosanchuk JD; Casadevall A; Pirofski L
Antimicrob Agents Chemother; 2004 May; 48(5):1624-9. PubMed ID: 15105113
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma.
Supiot S; Faivre-Chauvet A; Couturier O; Heymann MF; Robillard N; Kraeber-Bodéré F; Morandeau L; Mahé MA; Chérel M
Cancer; 2002 Feb; 94(4 Suppl):1202-9. PubMed ID: 11877746
[TBL] [Abstract][Full Text] [Related]
7. Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody.
Huber R; Seidl C; Schmid E; Seidenschwang S; Becker KF; Schuhmacher C; Apostolidis C; Nikula T; Kremmer E; Schwaiger M; Senekowitsch-Schmidtke R
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3922S-8S. PubMed ID: 14506190
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
[TBL] [Abstract][Full Text] [Related]
9. Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens.
Bryan RA; Guimaraes AJ; Hopcraft S; Jiang Z; Bonilla K; Morgenstern A; Bruchertseifer F; Del Poeta M; Torosantucci A; Cassone A; Nosanchuk JD; Casadevall A; Dadachova E
Mycopathologia; 2012 Jun; 173(5-6):463-71. PubMed ID: 22048869
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy of infection with Bi-labeled antibodies.
Dadachova E
Curr Radiopharm; 2008 Sep; 1(3):234-239. PubMed ID: 20228957
[TBL] [Abstract][Full Text] [Related]
11. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy.
Junghans RP; Dobbs D; Brechbiel MW; Mirzadeh S; Raubitschek AA; Gansow OA; Waldmann TA
Cancer Res; 1993 Dec; 53(23):5683-9. PubMed ID: 8242624
[TBL] [Abstract][Full Text] [Related]
13. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study.
Bethge WA; Wilbur DS; Storb R; Hamlin DK; Santos EB; Brechbiel MW; Sandmaier BM
Transplantation; 2004 Aug; 78(3):352-9. PubMed ID: 15316362
[TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA.
Bryan RA; Jiang Z; Jandl T; Strauss J; Koba W; Onyedika C; Morgenstern A; Bruchertseifer F; Epstein AL; Dadachova E
Expert Rev Anticancer Ther; 2014 Oct; 14(10):1243-9. PubMed ID: 25156106
[TBL] [Abstract][Full Text] [Related]
16. Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model.
Song EY; Qu CF; Rizvi SM; Raja C; Beretov J; Morgenstern A; Apostolidis C; Bruchertseifer F; Perkins A; Allen BJ
Cancer Biol Ther; 2008 Jan; 7(1):76-80. PubMed ID: 18347423
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunotherapy as a Novel Approach in HIV, Bacterial, and Fungal Infectious Diseases.
Helal M; Dadachova E
Cancer Biother Radiopharm; 2018 Oct; 33(8):330-335. PubMed ID: 30133305
[TBL] [Abstract][Full Text] [Related]
18. 213Bi radioimmunotherapy with an anti-mCD138 monoclonal antibody in a murine model of multiple myeloma.
Chérel M; Gouard S; Gaschet J; Saï-Maurel C; Bruchertseifer F; Morgenstern A; Bourgeois M; Gestin JF; Bodéré FK; Barbet J; Moreau P; Davodeau F
J Nucl Med; 2013 Sep; 54(9):1597-604. PubMed ID: 24003167
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunotherapy of methicillin-resistant Staphylococcus aureus in planktonic state and biofilms.
van Dijk B; Allen KJH; Helal M; Vogely HC; Lam MGEH; de Klerk JMH; Weinans H; van der Wal BCH; Dadachova E
PLoS One; 2020; 15(5):e0233086. PubMed ID: 32407350
[TBL] [Abstract][Full Text] [Related]
20. Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection.
Dadachova E; Bryan RA; Apostolidis C; Morgenstern A; Zhang T; Moadel T; Torres M; Huang X; Revskaya E; Casadevall A
J Infect Dis; 2006 May; 193(10):1427-36. PubMed ID: 16619191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
